Anila Lingamneni - May 6, 2024 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Signature
/s/ Thomas V. Powers, attorney-in-fact for Ms. Lingamneni
Stock symbol
HAE
Transactions as of
May 6, 2024
Transactions value $
-$218,975
Form type
4
Date filed
5/8/2024, 04:21 PM
Previous filing
Apr 17, 2024
Next filing
May 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Sale -$219K -2.31K -15.79% $95.00 12.3K May 6, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction pursuant to an existing 10b5-1 trading plan dated June 2, 2023 (fully executed as of June 5, 2023).
F2 This number includes unvested restricted stock units previously reported as well as 289 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 30, 2024.